After a month of steady decline that bottomed out with a five-year low, the closely watched XBI biotech index rose more than 10% last week, giving long-suffering investors some hope that the worst might at last be over.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,